Shreetech Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.75 M
as on 16-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.60 M
as on 16-12-2024
- Revenue 1.63%
(FY 2016)
- Profit 1090.22%
(FY 2016)
- Ebitda 123.96%
(FY 2016)
- Net Worth 1589.21%
(FY 2016)
- Total Assets 7.24%
(FY 2016)
About Shreetech Life Sciences
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹3.60 M.
Sumit Bhatia and Shalini Bhatia serve as directors at the Company.
- CIN/LLPIN
U52390DL2012PTC240839
- Company No.
240839
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Shreetech Life Sciences Private Limited offer?
Shreetech Life Sciences Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Water Testing Equipment, Water Treatment & Purification Plant, Water Purification Plants, TDS Meter, Analyzers & Analytical Instruments, Colorimetric Analyzer, Laboratory & Lab Equipment, Science Laboratory Equipment.
Who are the key members and board of directors at Shreetech Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Bhatia  | Director | 24-Aug-2012 | Current |
| Shalini Bhatia | Director | 04-May-2018 | Current |
Financial Performance of Shreetech Life Sciences.
Shreetech Life Sciences Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 1.63% increase. The company also saw a substantial improvement in profitability, with a 1090.22% increase in profit. The company's net worth Soared by an impressive increase of 1589.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreetech Life Sciences?
In 2017, Shreetech Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 31 Dec 2018 | ₹3.60 M | Open |
How Many Employees Work at Shreetech Life Sciences?
Unlock and access historical data on people associated with Shreetech Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shreetech Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreetech Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
